ACASTI PHARMA INC (ACST)
CA00430K8656 - Common Stock
| MRQ (2023-12-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | 2021 (2021-3-31) | 2020 (2020-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | N/A | |||
| Cash Equivalents | 18.55M | 27.90M | 30.30M | 50.90M | 14.20M | |||
| Marketable Securities | 6.57M | 0.00 | 13.30M | 9.80M | 0.00 | |||
| Receivables | 959.00K | 800.00K | 500.00K | 500.00K | 500.00K | |||
| Inventories | N/A | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 811.00K | 600.00K | 1.10M | 1.10M | 3.70M | |||
| Total Current Assets | 26.88M | 29.30M | 45.30M | 62.40M | 18.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 35.00K | 600.00K | 600.00K | 100.00K | 100.00K | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Goodwill | 8.14M | 8.10M | 13.00M | N/A | N/A | |||
| Intangibles | 41.13M | 41.10M | 69.80M | 0.00 | 4.20M | |||
| Other Non-Current Assets | N/A | N/A | N/A | N/A | 470.00K | |||
| Total Non-Current Assets | 49.30M | 49.80M | 83.30M | 100.00K | 4.40M | |||
| TOTAL ASSETS | 76.19M | 79.10M | 128.60M | 62.50M | 22.90M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | 104.00K | 0.00 | 0.00 | |||
| Accrued Expenses | 325.00K | 1.20M | 1.30M | 900.00K | 1.40M | |||
| Accounts Payable | 1.45M | 2.10M | 2.00M | 700.00K | 5.90M | |||
| Other Current Liabilities | N/A | N/A | N/A | 770.00K | 1.36M | |||
| Total Current Liabilities | 1.77M | 3.40M | 3.30M | 1.60M | 7.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Deferred Taxes/Income | 6.40M | 7.30M | 16.90M | N/A | N/A | |||
| Other Non-Current Liabilities | 3.33M | 400.00K | 200.00K | 5.20M | 2.50M | |||
| Total Non-Current Liabilities | 9.73M | 7.80M | 17.10M | 5.20M | 2.50M | |||
| TOTAL LIABILITIES | 11.51M | 11.20M | 20.40M | 6.80M | 9.90M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -207.95M | -198.30M | -155.80M | -146.00M | -126.30M | |||
| Additional Paid In Capital | 17.63M | 14.00M | 12.20M | 10.80M | 9.80M | |||
| Common Shares | 261.04M | 258.30M | 258.00M | 197.20M | 137.40M | |||
| Other Shareholders' Equity | -6.04M | -6.00M | -6.00M | -6.30M | -7.90M | |||
| Shares Outstanding | 9.40M | 7.40M | 7.40M | 4.30M | 1.90M | |||
| Tangible Book Value per Share | 1.64 | 2.54 | 3.45 | 12.95 | 4.63 | |||
| Total Shareholders' Equity | 64.68M | 68.00M | 108.30M | 55.70M | 13.00M | |||
| TOTAL LIABILITIES AND EQUITY | 76.19M | 79.10M | 128.60M | 62.50M | 22.90M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 15.19 | 8.62 | 13.73 | 39.00 | 2.50 | |||
| Return On Assets (ROA) | -50.89% | -53.64% | -7.64% | -31.49% | -111.40% | |||
| Return On Equity (ROE) | -59.94% | -62.40% | -9.07% | -35.33% | -196.23% | |||
All data in USD